A selective peroxisome proliferator-activated receptor δ agonist PYPEP suppresses atherosclerosis in association with improvement of the serum lipoprotein profiles in human apolipoprotein B100 and cholesteryl ester transfer protein double transgenic mice

Abstract Objective Although peroxisome proliferator-activated receptor (PPAR) δ agonists have been shown to improve the serum lipoprotein profiles in humans, the impact of the changes in these lipoprotein profiles on atherosclerosis remains to be elucidated. The aim of this study was to investigate...

Full description

Saved in:
Bibliographic Details
Published in:Metabolism, clinical and experimental Vol. 65; no. 1; pp. 16 - 25
Main Authors: Naya, Noriyuki, Fukao, Keita, Nakamura, Akemi, Hamada, Tadateru, Sugimoto, Masayuki, Kojima, Midori, Yoshimura, Norito, Uwabe, Ken-Ichiro, Imagawa, Keiichi, Nomura, Kohji, Hara, Seijiro, Nakano, Toru, Iwasaki, Takanori, Shinosaki, Toshihiro, Hanasaki, Kohji
Format: Journal Article
Language:English
Published: United States Elsevier Inc 2016
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first